ASX Filings

Notification regarding unquoted securities - OPT

December 16, 2024

Notification regarding unquoted securities - OPT

December 16, 2024

Opthea's Wet AMD Program to be Featured at FLORetina 2024

November 26, 2024

Opthea Participate in Citi 2024 Global Healthcare Conference

November 25, 2024

Initial Director's Interest Notice

November 15, 2024

Opthea Received A$15.9 Million R&D Tax Incentive

November 15, 2024

Results of Meeting

November 15, 2024

Director Appointment/Resignation

November 15, 2024

Chair's Address to Shareholders

November 15, 2024

Opthea's Wet AMD Program Featured at Ophthalmology Events

November 12, 2024